Source: Annual Congress 2006 - Epidemiology, rare tumors (2), miscellaneous
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. S. Yurdakul, A. Varol, D. Taskin, C. Kurul, J. Karakaya, S. Demircan, C. Ozturk (Ankara, Turkey). The role of tumor size in patients with lung cancer. Eur Respir J 2006; 28: Suppl. 50, 624

Member's Comments

No comment yet.

Related content which might interest you: Does the lung function affect the survival time in patients with resected non-small cell lung cancer? Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007 Influence of the lung resection to small airways function in patients with limited and normal lung function and primary non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 718s Year: 2006 CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Small cell lung cancer in patients with elderly Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007 Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 The impact of thrombosis events in excised tumor tissues on the prognosis of non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 A novel biologic classification of non-small cell lung cancer Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 The influence of secondary infectious process on non-small cell lung cancer (NSCLC) patients survival Source: Eur Respir J 2007; 30: Suppl. 51, 280s Year: 2007 Are there any peculiarities in tumour behavior and different tumour markers expression in nonsmall cell lung cancer? Source: Eur Respir J 2001; 18: Suppl. 33, 232s Year: 2001 Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 The role of P53 tumor suppressor gene mutations in early diagnosis of lung cancer among patients with solitary pulmonary nodule Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 The role of VATS in the staging of non small cell lung cancer Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Markers of angiogenesis in serum are correlating with disease progress in lung cancer Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 Treatment choices in lung cancer patients with brain metastasis Source: Eur Respir J 2001; 18: Suppl. 33, 378s Year: 2001 Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009